Emergent Biosolutions (EBS)
(Delayed Data from NYSE)
$5.63 USD
-0.25 (-4.25%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $5.63 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Emergent Biosolutions Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
EBS 5.63 -0.25(-4.25%)
Will EBS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EBS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EBS
5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost
Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions
EBS: What are Zacks experts saying now?
Zacks Private Portfolio Services
5 Broker-Loved Stocks to Watch Amid Signs of Easing Trade Woes
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates
Axsome (AXSM) Moves 4.2% Higher: Will This Strength Last?
Other News for EBS
Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. ...
New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential ...
Emergent BioSolutions (EBS) Explores Brincidofovir for Mpox Treatment
Emergent BioSolutions (EBS) Applauds Naloxone Accessibility in U.S. House
Emergent BioSolutions 'applauds' OTC naloxone availability in U.S. House